Two paternal genomes are compatible with dopaminergic in vitro and in vivo differentiation

International Journal of Developmental Biology

Volumn 54, Issue 11-12, 2011, Pages 1755-1762

  Choi, Soon Won ^a   Eckardt, Sigrid ^b   Ahmad, Ruhel ^a   Wolber, Wanja ^c   Mclaughlin, K John ^b   Sirén, Anna Leena ^c   Müller, Albrecht M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Androgenetic; Differentiation; Dopaminergic neuron; Embryonic stem cell

Indexed keywords

ANDROGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLASTOCYST; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CHIMERA; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION; GENOME; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL CULTURE; NONHUMAN; PATERNAL GENOME; PRIORITY JOURNAL;

ANIMALS; BLASTOCYST; BRAIN; CELL DIFFERENTIATION; CELL LINE; CHIMERA; DOPAMINE; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME; MALE; MICE; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; ZYGOTE;

MURINAE;

EID: 80051526420     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103188sc     Document Type: Article

References (58)

1. ALLEN, N D., BARTON, S.C., HILTON, K., NORRIS, M.L. and SURANI, M.A. (1994). A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 120: 1473-1482.
2. BARBERI, T., KLIVENYI, P., CALINGASAN, N.Y., LEE, H., KAWAMATA, H., LOONAM, K., PERRIER, A.L., BRUSES, J., RUBIO, M.E., TOPF, N. et al. (2003). Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol 21: 1200-1207.
3. BARTON, S.C., FERGUSON-SMITH, A.C., FUNDELE, R. and SURANI, M.A. (1991). Influence of paternally imprinted genes on development. Development 113: 679-687.
4. BARTON, S.C., SURANI, M.A. and NORRIS, M.L. (1984). Role of paternal and maternal genomes in mouse development. Nature 311: 374-376.
5. BIBEL, M., RICHTER, J., LACROIX, E. and BARDE, Y.A. (2007). Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat Protoc 2: 1034-1043.
6. BJORKLUND, L.M., SANCHEZ-PERNAUTE, R., CHUNG, S., ANDERSSON, T., CHEN, I.Y., MCNAUGHT, K.S., BROWNELL, A.L., JENKINS, B.G., WAHLESTEDT, C., KIM, K.S. et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99: 2344-2349.
7. CARON, H., VAN SLUIS, P., VAN HOEVE, M., DE KRAKER, J., BRAS, J., SLATER, R., MANNENS, M., VOUTE, P.A., WESTERVELD, A. and VERSTEEG, R. (1993). Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4: 187-190.
8. CATTANACH, B.M. and KIRK, M. (1985). Differential activity of maternally and paternally derived chromosome regions in mice. Nature 315: 496-498.
9. CHIBA, S., LEE, Y.M., ZHOU, W. and FREED, C.R. (2008). Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 26: 2810-2820.
10. CHIN, M.H., MASON, M.J., XIE, W., VOLINIA, S., SINGER, M., PETERSON, C., AMBARTSUMYAN, G., AIMIUWU, O., RICHTER, L., ZHANG, J. et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123.
11. CIBELLI, J.B., GRANT, K.A., CHAPMAN, K.B., CUNNIFF, K., WORST, T., GREEN, H.L., WALKER, S.J., GUTIN, P.H., VILNER, L., TABAR, V. et al. (2002). Parthenogenetic stem cells in nonhuman primates. Science 295: 819.
12. DEIERBORG, T., SOULET, D., ROYBON, L., HALL, V. and BRUNDIN, P. (2008). Emerging restorative treatments for Parkinson's disease. Prog Neurobiol 85: 407-432.
13. DENG, J., SHOEMAKER, R., XIE, B., GORE, A., LEPROUST, E.M., ANTOSIEWICZ-BOURGET, J., EGLI, D., MAHERALI, N., PARK, I.H., YU, J. et al. (2009). Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 27: 353-360.
14. DINGER, T.C., ECKARDT, S., CHOI, S.W., CAMARERO, G., KUROSAKA, S., HORNICH, V., MCLAUGHLIN, K.J. and MULLER, A.M. (2008). Androgenetic embryonic stem cells form neural progenitor cells in vivo and in vitro. Stem Cells 26: 1474-1483.
15. DOI, A., PARK, I.H., WEN, B., MURAKAMI, P., ARYEE, M.J., IRIZARRY, R., HERB, B., LADD-ACOSTA, C., RHO, J., LOEWER, S. et al. (2009). Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genef 41: 1350-1353.
16. DRAPER, J.S. and NAGY, A. (2007). Improved embryonic stem cell technologies. Handb Exp Pharmacol. pp. 107-128.
17. ECKARDT, S., DINGER, T.C., KUROSAKA, S., LEU, N.A., MULLER, A.M. and MCLAUGHLIN, K.J. (2008). In vivo and in vitro differentiation of uniparental embryonic stem cells into hematopoietic and neural cell types. Organogenesis 4: 33-41.
18. ECKARDT, S., LEU, N A., BRADLEY, H.L., KATO, H., BUNTING, K.D. and MCLAUGHLIN, K.J. (2007). Hematopoietic reconstitution with androgenetic and gynogenetic stem cells. Genes Dev 21: 409-419.
19. FREED, W.J., CHEN, J., BACKMAN, C.M., SCHWARTZ, C.M., VAZIN, T., CAI, J., SPIVAK, C.E., LUPICA, C.R., RAO, M.S. and ZENG, X. (2008). Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons. PLoS One 3: e1422.
20. FUNDELE, R., NORRIS, M.L., BARTON, S.C., REIK, W. and SURANI, M.A. (1989). Systematic elimination of parthenogenetic cells in mouse chimeras. Development 106: 29-35.
21. HEDLUND, E. and PERLMANN, T. (2009). Neuronal cell replacement in Parkinson's disease. J Intern Med 266: 358-371.
22. HERMANN, A., MAISEL, M., LIEBAU, S., GERLACH, M., KLEGER, A., SCHWARZ, J., KIM, K.S., ANTONIADIS, G., LERCHE, H. and STORCH, A. (2006). Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem 98: 629-640.
23. HERNANDEZ, L., KOZLOV, S., PIRAS, G. and STEWART, C.L. (2003). Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci USA 100: 13344-13349.
24. HU, B.Y., WEICK, J.P., YU, J., MA, L.X., ZHANG, X.Q., THOMSON, J.A. and ZHANG, S.C. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107: 4335-4340.
25. JANKOVIC, J. (2008). Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79: 368-376.
26. KATZ, F., WEBB, D., GIBBONS, B., REEVES, B., MCMAHON, C., CHESSELLS, J. and MITCHELL, C. (1992). Possible evidence for genomic imprinting in childhood acute myeloblasts leukaemia associated with monosomy for chromosome 7. Br J Haematol 80: 332-326.
27. KAWASAKI, H., MIZUSEKI, K., NISHIKAWA, S., KANEKO, S., KUWANA, Y., NAKANISHI, S., NISHIKAWA, S.I. and SASAI, Y. (2000). Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28: 31-40.
28. KEVERNE, E.B., FUNDELE, R., NARASIMHA, M., BARTON, S.C. and SURANI, M.A. (1996). Genomic imprinting and the differential roles of parental genomes in brain development. Brain Res Dev Brain Res 92: 91-100.
29. KIM, J.H., AUERBACH, J.M., RODRIGUEZ-GOMEZ, J.A., VELASCO, I., GAVIN, D., LUMELSKY, N., LEE, S.H., NGUYEN, J., SANCHEZ-PERNAUTE, R., BANKIEWICZ, K. et al. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56.
30. LENGERKE, C., KIM, K., LEROU, P. and DALEY, G.Q. (2007). Differentiation potential of histocompatible parthenogenetic embryonic stem cells. Ann N Y Acad Sci 1106: 209-218.
31. LINDVALL, O. and KOKAIA, Z. (2009). Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30: 260-267.
32. MANN, J.R., GADI, I., HARBISON, M.L., ABBONDANZO, S.J. and STEWART, C.L. (1990). Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 62: 251-260.
33. MAXWELL, S.L. and LI, M. (2005). Midbrain dopaminergic development in vivo and in vitro horn embryonic stem cells. J Anat 207: 209-218.
34. MCGRATH, J. and SOLTER, D. (1984). Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37: 179-183.
35. MENENDEZ, P., WANG, L. and BHATIA, M. (2005). Genetic manipulation of human embryonic stem cells: a system to study early human development and potential therapeutic applications. Curr Gene Ther 5: 375-385.
36. NARASIMHA, M., BARTON, S.C. and SURANI, M.A. (1997). The role of the paternal genome in the development of the mouse germ line. Curr Biol 7: 881-884.
37. NISHIKAWA, S., OGAWA, M., KUNISADA, T. and KODAMA, H. (1988). B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur J Immunol 18: 1767-1771.
38. OKABE, S., FORSBERG-NILSSON, K., SPIRO, A.C., SEGAL, M. and MCKAY, R.D. (1996). Development of neuronal precursor cells andfunctional postmitotic neurons from embryonic stem cells in vitro. Mech Dev 59: 89-102.
39. OLANOW, C.W. and TATTON, W.G. (1999). Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144.
40. PARISH, C.L. and ARENAS, E. (2007). Stem-cell-based strategies for the treatment of Parkinson's disease. Neurodegener Dis 4: 339-347.
41. PRELLE, K., ZINK, N. and WOLF, E. (2002). Pluripotent stem cells - model of embryonic development, tool for gene targeting, and basis of cell therapy. Anat Histol Embryol 31: 169-186.
42. REVAZOVA, E.S., TUROVETS, N.A., KOCHETKOVA, O.D., KINDAROVA, L.B., KUZMICHEV, L.N., JANUS, J.D. and PRYZHKOVA, M.V. (2007). Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 9: 432-449.
43. ROBERTSON EJ, K.M., BRADLEY A, EVANS MJ. (1983). Isolation, properties, and karyotype analysis of pluripotential (EK) cell lines from normal and parthenogenetic embryos. In Teratocarcinomal Stem Cells Cold Spring Harbor Conferences on Cell Proliferation (Silver LM, Martin GR, Strickland S), Cold Spring Harbor Laboratory, New York, pp. 647-663.
44. RODRIGUEZ-GOMEZ, J.A., LU, J.Q., VELASCO, I., RIVERA, S., ZOGHBI, S.S., LIOW, J.S., MUSACHIO, J.L., CHIN, F.T., TOYAMA, H., SEIDEL, J. et al. (2007). Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 25: 918-928.
45. SANCHEZ-PERNAUTE, R., LEE, H., PATTERSON, M., RESKE-NIELSEN, C., YOSHIZAKI, T., SONNTAG, K.C., STUDER, L. and ISACSON, O. (2008). Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain 131: 2127-2139.
46. SASAI, Y. (2002). Generation of dopaminergic neurons from embryonic stem cells. J Neurol 249 Suppl 2: 1141-1144.
47. SATO, S., YAGI, S., ARAI, Y., HIRABAYASHI, K., HATTORI, N., IWATANI, M., OKITA, K , OHGANE, J., TANAKA, S., WAKAYAMA, T. et al. (2010). Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Genes Cells 15: 607-618.
48. SCRABLE, H., CAVENEE, W., GHAVIMI, F., LOVELL, M., MORGAN, K. and SAPIENZA, C. (1989). A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 86: 7480-7484.
49. SOLTER, D. (2006). Imprinting today: end of the beginning or beginning of the end? Cytogenet Genome Res 113: 12-16.
50. STURM, K.S., FLANNERY, M.L. and PEDERSEN, R.A. (1994). Abnormal development of embryonic and extraembryonic cell lineages in parthenogenetic mouse embryos. Dev Dyn 201: 11-28.
51. SURANI, M.A., BARTON, S.C. and NORRIS, M.L. (1984). Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308: 548-550.
52. TAKAGI, Y., TAKAHASHI, J., SAIKI, H., MORIZANE, A., HAYASHI, T., KISHI, Y., FUKUDA, H., OKAMOTO, Y., KOYANAGI, M., IDEGUCHI, M. et al. (2005). Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115: 102-109.
53. TERAMURA, T., ONODERA, Y., MURAKAMI, H., ITO, S., MIHARA, T., TAKEHARA, T., KATO, H., MITANI, T., ANZAI, M., MATSUMOTO, K. et al. (2009). Mouse androgenetic embryonic stem cells differentiated to multiple cell lineages in three embryonic germ layers in vitro. J Reprod Dev 55: 283-292.
54. TORIUMI, H., YOSHIKAWA, M., MATSUDA, R., NISHIMURA, F., YAMADA, S., HIRABAYASHI, H., NAKASE, H., NONAKA, J., OUJI, Y., ISHIZAKA, S. et al. (2009). Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement. Neurol Res 31: 220-227.
55. VIERBUCHEN, T., OSTERMEIER, A., PANG, Z.P., KOKUBU, Y., SUDHOF, T.C. and WERNIG, M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463: 1035-1041.
56. WILKINSON, L.S., DAVIES, W. and ISLES, A.R. (2007). Genomic imprinting effects on brain development and function. Nat Rev Neurosci 8: 832-843.
57. YAMANAKA, S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39-49.
58. YANG, D., ZHANG, Z.J., OLDENBURG, M., AYALA, M. and ZHANG, S C. (2008). Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 26: 55-63.